The European Medicines Agency recommended that CSL Ltd.’s drug Tavneos be pulled from the market after finding it was approved based on allegedly incorrect and misleading data, adding pressure to its US manufacturer, Amgen Inc.Read More
Data Integrity Questions Lead Europe to Back Tavneos’ Withdrawal
MGSN.net
